v3.26.1
Equity Incentive Plans and Stock-Based Compensation
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans and Stock-Based Compensation Equity Incentive Plans, Stock-Based Compensation and Stock Repurchase Programs
Equity Incentive Plans

2014 Equity Incentive Plan and 2023 Stock Incentive Plan

The 2014 Equity Incentive Plan (the “2014 Plan”) was in effect until it was replaced by the 2023 Stock Incentive Plan (the “2023 Plan”) on April 1, 2023. No further grants will be made under the 2014 Plan. Both the 2014 Plan and 2023 Plan provide for the granting of stock options, restricted stock awards, restricted stock units (“RSUs”), market performance-based RSUs (“PSUs”), stock appreciation rights, performance units and performance shares to our employees, consultants and members of our Board of Directors. As of June 30, 2026, we had 1,883,555 shares available for future grant under the 2023 Plan.

2014 Employee Stock Purchase Plan

The 2014 Employee Stock Purchase Plan, as amended (the “Amended 2014 Purchase Plan”) provides employees with an opportunity to purchase our common stock through accumulated contributions, up to a maximum of 10% of eligible compensation, with offering periods of six months in duration, beginning on or about December 1 and June 1 each year. As of June 30, 2026, the Company had 2,683,098 shares available for future issuance under the Amended 2014 Purchase Plan.
Stock-Based Compensation

A summary of our stock-based compensation expense is as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Stock-based compensation by type of award:
Stock awards$8,647 $4,171 $13,222 $9,964 
Employee stock purchase rights319 238 565 463 
$8,966 $4,409 $13,787 $10,427 
Stock-based compensation by category of expense:
Cost of net revenue$584 $479 $972 $1,103 
Sales and marketing1,816 940 2,957 1,834 
Research and development1,942 1,176 3,434 2,567 
General and administrative4,624 1,814 6,424 4,923 
$8,966 $4,409 $13,787 $10,427 

As of June 30, 2026, the Company had $38.0 million of unrecognized stock-based compensation expense related to unvested stock-based awards and employee stock purchase rights, which will be recognized over a weighted-average period of 1.8 years.

Stock Awards

The Company has granted RSUs to its employees, consultants and members of the Board of Directors, and PSUs to certain executives and employees. The Company’s PSUs have market performance-based vesting conditions as well as service-based vesting conditions. As of June 30, 2026, there were 2,190,679 RSUs and 568,376 PSUs outstanding.

The following table summarizes our stock award activities and related information:
Number of Shares (thousands)Weighted-Average Grant Date Fair Value Per ShareWeighted-Average Remaining Vesting Term
(years)
Aggregate Fair Value (thousands)
Nonvested as of December 31, 20253,086 $15.83 
Granted732 24.01 
Released(909)15.36 
Canceled(150)16.49 
Nonvested as of June 30, 20262,759 $18.12 1.25$103,078 

The aggregate fair value of stock awards released was $8.3 million and $4.0 million for the three months ended June 30, 2026 and 2025, respectively, and was $14.0 million and $10.7 million for the three and six months ended June 30, 2026 and 2025, respectively.

Stock Repurchase Programs

On November 1, 2022, the Company announced that the Board of Directors authorized a stock repurchase program of up to $50 million of its common stock over a period of twelve months. On November 7, 2023, the Company announced that the Board of Directors authorized a stock repurchase program of up to $50 million of its common stock over a period of twelve months. These repurchase programs were active for twelve months and are expired.
On November 7, 2024, the Company announced that the Board of Directors authorized a stock repurchase program of up to $50 million of its common stock (the “2024 Program”). The 2024 Program did not have a specified term or termination date. The Board of Directors terminated the 2024 Program on May 1, 2025.

On May 1, 2025, the Company announced that the Board of Directors authorized a new stock repurchase program of up to $75 million of its common stock (the “2025 Program”). The 2025 Program does not have a specified term or termination date. During the three months ended June 30, 2026, we did not repurchase any shares under the 2025 Program and during the six months ended June 30, 2026, we repurchased 16,708 shares for a total of $0.3 million or $18.96 per share. As of June 30, 2026, the Company had $53.1 million available to repurchase shares under the 2025 Program.

In addition to repurchasing shares under the Company’s repurchase programs, we withhold shares from certain executives to satisfy income tax withholding and remittance obligations resulting from the vesting of RSU and PSU awards.

Under the Company’s stock repurchase programs, repurchased shares are held in treasury at cost. The Company’s stock repurchase programs do not obligate it to acquire any specific number of shares. Shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities and Exchange Act of 1934 (the “Exchange Act”).